Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000439637 | SCV000529186 | likely benign | not specified | 2016-07-07 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000630705 | SCV000751672 | likely benign | not provided | 2023-11-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000439637 | SCV002755125 | likely benign | not specified | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002502560 | SCV002813633 | likely benign | Medulloblastoma; Familial dysautonomia | 2021-12-30 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001828422 | SCV002082148 | likely benign | Familial dysautonomia | 2018-06-25 | no assertion criteria provided | clinical testing |